Last reviewed · How we verify

NCT04520282: HISS

Hemostatic Variables In Snakebite Study

Completed Last updated 7 March 2024
What this trial tests

trial in Snake Bites in 96 participants. Completed in 9 August 2023.

Timeline
15 March 2022
Primary endpoint
31 July 2023
9 August 2023

Quick facts

Lead sponsorJubilee Mission Medical College and Research Institute
StatusCompleted
Study typeOBSERVATIONAL
Enrollment96
Start date15 March 2022
Primary completion31 July 2023
Estimated completion9 August 2023
Sites1 location across India

Conditions studied

Sponsor

Jubilee Mission Medical College and Research Institute

Who can join

Eligibility, any sex, with Snake Bites or Coagulopathy, Consumption. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background Novelty The global assays of coagulation, namely the viscoelastometric tests and clot waveform has never been studied in detail before in snakebite victims. The pathophysiology of VICC including specific factor deficiencies and serial trend in blood cell indices amongst various hematotoxic snakebite in the region is not known. No Indian study to date has systematically examined the changes in early laboratory tests results in envenomed and non envenomed snakebite victims.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Jubilee Mission Medical College and Research Institute trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04520282.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing